Results for tag: "Safinamide"

Safinamide is a drug used to treat Parkinson's disease. It is a centrally acting reversible inhibitor of monoamine oxidase type B (MAO-B), which is an enzyme that breaks down dopamine in the brain. Safinamide is used to improve motor symptoms in patients with Parkinson's disease, such as tremor, stiffness, and difficulty walking. It is also used to reduce the amount of "off" time, when the effects of other Parkinson's medications wear off. Safinamide is usually taken in combination with other medications for Parkinson's disease. Safinamide is a relatively new drug in the Central Nervous System (CNS) drug market. It is approved in the United States, Europe, and other countries for the treatment of Parkinson's disease. It is also being studied for its potential to treat other CNS disorders, such as Alzheimer's disease and Huntington's disease. Several companies are involved in the Safinamide market, including Bial, Teva Pharmaceuticals, and Zambon. Bial is the developer of the drug, while Teva Pharmaceuticals and Zambon are responsible for its marketing and distribution. Show Less Read more